Clinical Trial Update: Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating bortezomib for newly diagnosed multiple myeloma has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2012-09-28